BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 9866452)

  • 21. Saturated treatments and measles resurgence episodes in South Africa: a possible linkage.
    Lacitignola D
    Math Biosci Eng; 2013 Aug; 10(4):1135-57. PubMed ID: 23906205
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cost effectiveness and policy announcement: The case of measles mandatory vaccination.
    Flaig J; Houy N; Michel P
    J Theor Biol; 2020 Jan; 485():110028. PubMed ID: 31568787
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Measles epidemic attributed to inadequate vaccination coverage--Campania, Italy, 2002.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2003 Oct; 52(43):1044-7. PubMed ID: 14586297
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Measles takes root in Sweden again. Reduced vaccination will result in epidemics, about 25 000 cases are expected to occur annually within a 15-year period].
    Asikainen T; Giesecke J; Svensson A
    Lakartidningen; 2003 Oct; 100(40):3126-30. PubMed ID: 14579663
    [No Abstract]   [Full Text] [Related]  

  • 25. [Measles in the Local Health Unit Naples 4: vaccination coverage, epidemic 2001-2002 and prevention strategies].
    Gigli L; Graziano M; Manetta G; Palombino R
    Ann Ig; 2004; 16(5):627-32. PubMed ID: 15552728
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Estimation of the time-dependent vaccine efficacy from a measles epidemic.
    Eichner M; Diebner HH; Schubert C; Kreth HW; Dietz K
    Stat Med; 2002 Aug; 21(16):2355-68. PubMed ID: 12210620
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Stability analysis and optimal control of an SIR epidemic model with vaccination.
    Kar TK; Batabyal A
    Biosystems; 2011; 104(2-3):127-35. PubMed ID: 21315798
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The influence of prophylactic vaccination on epidemic situation of infectious diseases illustrated by the epidemiology of measles in Poland in the years 1968-1998.
    Kalinowski P
    Ann Univ Mariae Curie Sklodowska Med; 2001; 56():327-32. PubMed ID: 11977334
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Global stability of an SIR epidemic model with information dependent vaccination.
    Buonomo B; D'Onofrio A; Lacitignola D
    Math Biosci; 2008 Nov; 216(1):9-16. PubMed ID: 18725233
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pulse vaccination strategies in a metapopulation SIR model.
    Terry AJ
    Math Biosci Eng; 2010 Apr; 7(2):455-77. PubMed ID: 20462299
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Eradication of infectious diseases by vaccination].
    Saliou P
    Med Trop (Mars); 2007 Aug; 67(4):321-7. PubMed ID: 17926788
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Scheduling of measles vaccination in low-income countries: projections of a dynamic model.
    Bauch CT; Szusz E; Garrison LP
    Vaccine; 2009 Jun; 27(31):4090-8. PubMed ID: 19410622
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The unfinished measles immunization agenda.
    Strebel P; Cochi S; Grabowsky M; Bilous J; Hersh BS; Okwo-Bele JM; Hoekstra E; Wright P; Katz S
    J Infect Dis; 2003 May; 187 Suppl 1():S1-7. PubMed ID: 12721885
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Analysis of a delayed epidemic model with pulse vaccination and saturation incidence.
    Gao S; Chen L; Nieto JJ; Torres A
    Vaccine; 2006 Aug; 24(35-36):6037-45. PubMed ID: 16806597
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hopf bifurcation in epidemic models with a time delay in vaccination.
    Khan QJ; Greenhalgh D
    IMA J Math Appl Med Biol; 1999 Jun; 16(2):113-42. PubMed ID: 10399309
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A measles epidemic controlled by immunisation.
    Mansoor O; Blakely T; Baker M; Tobias M; Bloomfield A
    N Z Med J; 1998 Dec; 111(1079):467-71. PubMed ID: 9972200
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Stability analysis and optimal vaccination of an SIR epidemic model.
    Zaman G; Han Kang Y; Jung IH
    Biosystems; 2008 Sep; 93(3):240-9. PubMed ID: 18584947
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Feasibility of global measles eradication after interruption of transmission in the Americas.
    de Quadros CA; Andrus JK; Danovaro-Holliday MC; Castillo-Solórzano C
    Expert Rev Vaccines; 2008 Apr; 7(3):355-62. PubMed ID: 18393605
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Experience in global measles control, 1990-2001.
    Henao-Restrepo AM; Strebel P; John Hoekstra E; Birmingham M; Bilous J
    J Infect Dis; 2003 May; 187 Suppl 1():S15-21. PubMed ID: 12721887
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Household epidemics: modelling effects of early stage vaccination.
    Shaban N; Andersson M; Svensson A; Britton T
    Biom J; 2009 Jun; 51(3):408-19. PubMed ID: 19548285
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.